Coronavirus: Incapacity to jab will limit Covid vaccination | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 20, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 20, 2025
Incapacity to jab will limit Covid vaccination

Covid-19 in Bangladesh

Sadiqur Rahman
06 September, 2020, 11:00 pm
Last modified: 07 September, 2020, 11:28 am

Related News

  • 10 more Covid-19 cases reported in country
  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women

Incapacity to jab will limit Covid vaccination

“In the case of Covid-19 vaccination, Bangladesh will have to vaccinate approximately 162 million people rapidly, which would be extremely challenging with the existing immunisation programme”

Sadiqur Rahman
06 September, 2020, 11:00 pm
Last modified: 07 September, 2020, 11:28 am
Photo: Xinhua
Photo: Xinhua

Highlights

  1. The existing capacity only allows vaccination of around 4 million annually
  2. University of Birmingham, Heriot-Watt University, Brac University and Buet team up to design cold chain logistics for efficient mass vaccination for 162 million people

Even if Bangladesh gets required Covid-19 vaccines from Oxford University or other sources, can it vaccinate more than 162 million people within a year? The answer appears to be a 'no'.

For mass vaccination against the often lethal virus, the country needs to deliver vaccines to people countrywide at a scale and speed never thought before.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Every year, nearly four million children get antigens.

This is perhaps the maximum capacity of mass vaccination in the country.

It will require 10 years or more to bring all the population irrespective of ages under coverage if the mass vaccination begins with the existing capacity, say local experts.

That is why the whole immunisation programme needs to be re-engineered, particularly the cold chain which is mandatory to preserve the valuable vaccines, they add.  

Researchers at the University of Birmingham and Heriot-Watt University have collaborated with their counterparts at Brac University and Bangladesh University of Engineering and Technology (Buet) to assess the capacity and preparedness of Bangladesh's cold chain logistics.

The UK Research and Innovation is supporting the one and half year programme.

The outcome is expected to create a blueprint to help ensure a cost-effective model for blanket Covid-19 vaccination.

A cold chain is a temperature-controlled supply chain. To store, manage and transport life-saving vaccines, it takes a chain of precisely coordinated events, maintaining a desired low-temperature range.

Professor Farzana Munshi, an Economics teacher at the School of Humanities and Social Sciences of Brac University, has been working as a co-investigator under the project.

Farzana told The Business Standard, "The core element of the project is to evaluate the vaccine cold chain for mass scale Covid-19 vaccination in Bangladesh. It is crucial to assess the capacity and preparedness of the Covid-19 vaccination cold chain."

When the chief of the World Health Organisation (WHO) warns about Covid-19 vaccine nationalism, access to vaccines seems a major challenge for low-income countries lacking a robust refrigerated cooling system.

Although Bangladesh has one of the world's largest pharmaceutical and vaccine industries, with a vaccination framework supported by Gavi, the Vaccine Alliance, and the WHO, the country still lacks the capacity to deliver fast-track mass vaccination on an unprecedented scale.

Citing the WHO-2006 guidelines, Professor Farzana said the protocols for Covid-19 vaccine will require it to be kept in a narrow range between 2°C and 8°C, while in transport and storage. A thermally controlled envelope is required throughout the whole supply chain ranging from production to the final recipient of the vaccine.

With the country's current infrastructure, Bangladesh is able to deliver diphtheria, pertussis and tetanus (DPT) vaccines to 94% of the children. However, children below 14 years only accounted for around 27% or 44 million of the population in 2018.

"In the case of Covid-19 vaccination, Bangladesh will have to vaccinate approximately 162 million people rapidly, which would be extremely challenging with the existing immunisation programme," Farzana said.

According to Farzana, the project would assist policymakers in designing policies on the most sustainable interventions on the medical supply chain at regional, national scale for Covid-19 but also other potential future natural disasters and epidemics.

Cold chain is a crucial part of vaccination. Bangladesh still lacks sustainable cooling infrastructure and resilient electricity in rural communities.

Professor Ijaz Hossain, a chemical engineering teacher and dean of engineering at Buet, said "A cold chain covers a vast network combining refrigeration and storage facilities within central depots to grassroots distribution points and obviously the transportation. Lack of a sustainable cold chain will cause wastage and risk of less availability of vaccines from abroad."

In his opinion, Bangladesh's existing capacity of mass vaccination would be extremely inadequate to combat Covid-19. He will take part in designing the new cold chain after assessment of power availability and vaccine storage capacity at the grassroots.

On September 5, in a press release by the University of Birmingham, the project developer Toby Peters, also a Professor of Cold Economy at the university, commented, "Sustainable cold chain development will support Bangladesh's economy and help to support existing immunisation and cold chain programmes as well as a Covid-19 vaccine."

The project will help to design a roadmap for an efficient delivery mechanism to ensure that the vaccine will be provided globally, he added.

Researchers will also make their findings available to other countries in order to help public health planners evaluate their best options for creating sustainable temperature-controlled supply chains for health and medical supplies in epidemics and natural disasters, the release said.

Last month, the Bangladesh government gave the go-ahead for human trials of the Covid-19 vaccine developed by the Chinese company Sinovac Biotech.

The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and Sinovac will jointly conduct the trial. South Korea's LSK Global PS, a clinical research organisation, will monitor the trial data.

Top News

Coronavirus / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Smoke rises following an Israeli attack on the IRIB building, the country's state broadcaster, in Tehran, Iran, June 16, 2025. File Photo: Majid Asgaripour/WANA (West Asia News Agency) via REUTERS
    Iran says no nuclear talks under Israeli fire, Trump considers options
  • A view of burnt cars and a damaged residential building at an impact site in Be'er Sheva, Israel following Iran's missile strike on Israel on June 20, 2025. REUTERS/Amir Cohen
    Israel and Iran exchange new strikes as US weighs military role, diplomatic efforts intensify
  • News of The Day, 20 JUNE 2025
    News of The Day, 20 JUNE 2025

MOST VIEWED

  • BAT Bangladesh to shut Mohakhali factory, relocate HQ after lease rejection
    BAT Bangladesh to shut Mohakhali factory, relocate HQ after lease rejection
  • Mashrur Arefin appointed Chairman of the Association of Bankers Bangladesh
    Mashrur Arefin appointed Chairman of the Association of Bankers Bangladesh
  • Illustration: Ashrafun Naher Ananna/TBS Creative
    From 18m to 590m Swiss francs: Bangladeshi deposits fly high in Swiss banks
  • Students attend their graduation ceremony. REUTERS/Brian Snyder/File Photo
    US resumes student visas but orders enhanced social media vetting
  • Emergency workers at Soroka Medical Center after an Iranian missile strike, Israel June 19, 2025. Photo: Reuters
    Khamenei 'cannot continue to exist', Israeli defence minister says after hospital strike
  • Representational image. Photo: Bloomberg
    NBR’s policy reversal jolts oceangoing shipping, $3.5b investment, $1b yearly freight at risk

Related News

  • 10 more Covid-19 cases reported in country
  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women

Features

Monsoon in Bandarban’s hilly hiking trails means endless adventure — something hundreds of Bangladeshi hikers eagerly await each year. But the risks are sometimes not worth the reward. Photo: Collected

Tragedy on the trail: The deadly cost of unregulated adventure tourism in Bangladesh’s hills

22m | Panorama
BUET Professor Md Ehsan stands beside his newly designed autorickshaw—just 3.2 metres long and 1.5 metres wide—built for two passengers to ensure greater stability and prevent tipping. With a safety-focused top speed of 30 km/h, the vehicle can be produced at an estimated cost of Tk1.5 lakh. Photo: Junayet Rashel

Buet’s smart fix for Dhaka's autorickshaws

10h | Features
Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

1d | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

3d | Panorama

More Videos from TBS

News of The Day, 20 JUNE 2025

News of The Day, 20 JUNE 2025

32m | TBS News of the day
Israel strikes Iranian missile launch site

Israel strikes Iranian missile launch site

1h | TBS World
Deposits from Bangladeshis fly high in Swiss banks in 2024

Deposits from Bangladeshis fly high in Swiss banks in 2024

5h | TBS Stories
US joining Israeli strikes would cause hell: Iranian minister

US joining Israeli strikes would cause hell: Iranian minister

8h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net